Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies

Clinical Chemistry

Volumn 52, Issue 5, 2006, Pages 812-818

  MacRae, Andrew R ^a,g,i   Kavsak, Peter A ^a,g,h   Lustig, Viliam ^a,g   Bhargava, Rakesh ^b   Vandersluis, Rudy ^c   Palomaki, Glenn E ^d   Yerna, Marie Jeanne ^e   Jaffe, Allan S ^f  

^a Research Institute   (Canada)

^b Program of Critical Care Cardiopulmonary   (United States)

^c Lakeridge Health   (Canada)

^d WOMEN AND INFANTS HOSPITAL   (United States)

^e Immunotech   (France)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL RESEARCH; COHORT ANALYSIS; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PREVALENCE; RISK ASSESSMENT;

AMERICAN HEART ASSOCIATION; BIOLOGICAL MARKERS; BLOOD SPECIMEN COLLECTION; HUMANS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES; PREVALENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TROPONIN I;

EID: 33646359452     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.059550     Document Type: Article

References (20)

1. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, et al. AHA Scientific Statement. Case definitions for acute coronary heart disease in epidemiology and clinical research studies. Circulation 2003;108:2543-9.
2. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000;21:1502-13.
3. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
4. Eggers KM, Oldgren J, Nordenskjold A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004;148:574-81.
5. Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J 2006;in press.
6. Venge P, Lindahl B, Wallentin L. New generation cardiac troponin I assay for the access immunoassay system. Clin Chem 2001; 47:959-61.
7. Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004;50: 2279-85.
8. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002;144:981-6.
9. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32.
10. Kavsak P, Lustig V, MacRae AR. Clinical evaluation of the Beckman Coulter AccuTnI assay for the early detection of acute myocardial infarction [Abstract]. Clin Chem 2004;50:A15.
11. Agresti A, Coull BA. Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat 1998;52:119-26.
12. Armitage P, Berry G. Statistical Methods in Medical Research, 3rd ed. Oxford: Blackwell, 1994;125-8.
13. Wu AH, Apple FS, Gibier B, Jesse RL, Warshaw MM, Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21.
14. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
15. deWinter R, Koster RW, Sturk A, Sanders GT. Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995;92:3401-7.
16. Syed M, Khaja F, Rybicki BA, Wulbrecht N, Alam M, Sabbah HN, et al. Effect of delay on racial differences in thrombolysis for acute myocardial infarction. Am Heart J 2000;140:643-50.
17. McGinn AP, Rosamond WD, Goff DC, Taylor HA, Miles JS, Chambless L, Trends in prehospital delay and use of emergence medical services for acute myocardial infarction: experience in 4 US communities from 1987-2000. Am Heart J 2005;150:392-400.
18. Ottesen MM, Dixen U, Torp-Pedersen C, Køber L. Prehospital delay in acute coronary syndrome-an analysis of the components of delay. Int J Cardiol 2004;96:97-103.
19. Kavsak P, Bhargava R, Lustig V, MacRae AR, Palomaki GE, Vandersluis R, et al. Biomarker case study applying the 2003 AHA case definition for AMI in epidemiology and clinical research studies with the AccuTnI marker [Abstract]. Clin Chem 2005;51: A69.
20. Jaffe AS, Landt Y, Parvi CA, Abendschein DR, Geltman EM, Ladenson JH. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction. Clin Chem 1996;42:1770-6.